Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Vosevi (sofosbuvir/velpatasvir/voxilaprevir)
pCPA File Number:
21009
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
SR0529-000
pCPA Engagement Letter Issued:
2018-02-14
Negotiation Process Concluded:
2018-02-14